A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

NCT05939648 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: SARS-CoV-2 Bivalent mRNA Vaccine
OTHER: Saline

Sponsor

AIM Vaccine Co., Ltd.

Collaborators

[object Object]